Tag: LLP

Insights and updates

Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5% During the Forecast Period (2025-2034) Driven by Recent Approvals and Pipeline Advancements and Rising Awareness

[ad_1] The mitochondrial myopathies treatment market is expected to grow steadily, driven by the recent approval of FORZINITY and KYGEVVI, improved diagnosis, and rising awareness. Additionally, the expected launch of therapies such as Sonlicromanol (Khondrion; […]